This symposium from the 14th EEC Congress, held in Geneva, Switzerland 2022, provides real-world insights into the caregiver and clinician perspective of the diagnosis and management of aromatic L-amino acid decarboxylase (AADC) deficiency
This infographic, distributed during PTC Therapeutics symposium at ESGCT 2022, provides an overview of gene therapy as a strategy for the management of AADC deficiency
This infographic, distributed at the PTC Therapeutics symposium at ICNC 2022, provides an overview of the real-world diagnosis and management experience of aromatic L-amino acid decarboxylase (AADC) deficiency
This symposium, presented at ICNC 2022, provides an overview of the real-world diagnosis and management experience of aromatic L-amino acid decarboxylase (AADC) deficiency
This symposium, presented at CNS 2022, provides an overview of aromatic L-amino acid decarboxylase (AADC) deficiency management, with a focus on an investigational intraputaminal gene replacement therapy
This poster, presented at SSIEM 2022, provides an overview of the REVEAL-CP study, which has been designed to determine the prevalence of aromatic L-amino acid decarboxylase (AADC) deficiency
This poster, presented at SSIEM 2022, provides an overview of the AADCAware registry, which has been designed to improve understanding of AADC deficiency diagnosis, disease progression and standard of care
This poster, presented at ISPOR 2022, highlights how the severity of aromatic L-amino acid decarboxylase (AADC) deficiency symptoms may have an impact on the quality of life of both patients and caregivers
An overview of diagnostic challenges of aromatic L-amino acid decarboxylase (AADC) deficiency, key signs and symptoms, and diagnostic tests are discussed in the PTC Therapeutics symposium at the 2022 EPNS Congress
This infographic, distributed at the 14th EPNS Congress, held in Glasgow in April 2022, provides an overview of the challenges in recognizing and diagnosing aromatic L-amino acid decarboxylase (AADC) deficiency
View our symposium presented at ISPMD 2022, held in Barcelona, Spain, which discusses the potential role of an investigational gene therapy treatment in the management of AADC deficiency
This infographic, distributed at ISPMD 2022, provides an overview on the rare nature of AADC deficiency
The key findings of a UK study into the feasibility of a mobile domiciliary phlebotomy service to promote clinical trial recruitment are presented in our poster from ISPMD 2022, held in Barcelona, Spain
The key findings of a post-hoc analysis of the clinical trial results for an investigational gene therapy are discussed in our poster from ISPMD 2022, held in Barcelona, Spain
Year
Therapy area
Congress
Type
Topic